COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,386 Articles (22,816 medRxiv, 8,570 bioRxiv)

Most recent first Previous |  Page 1516: Articles 15151-15160  | Next

Monoclonal Antibody Treatment, Prophylaxis and Vaccines Combined to Reduce SARS CoV-2 Spread
Kamal, M. A., Kuznik, A., Qi, L., Wiecek, W., Hussein, M., Hassan, H. E., Patel, K., Obadia, T., Toroghi, M. K., Conrado, D. J., Al-Huniti, N., Casciano, R., O'Brien, M. P., Barnabas, R. V., Cohen, M. S., Smith, P. F.
10.1101/2021.05.21.21257624 — Posted: 2021-05-25
Association of Intravenous Bamlanivimab Use with Reduced Hospitalization, Intensive Care Unit Admission, and Mortality in Patients with Mild to Moderate COVID-19
Ganesh, R., Pawlowski, C., O'Horo, J. C., Arndt, L. L., Arndt, R., Bell, S. J., Bierle, D. M., Destro Borgen, M., Hanson, S. N., Heyliger, A., Larsen, J. J., Lenehan, P. J., Orenstein, R., Puranik, A., Speicher, L. L., Tulledge-Scheitel, S. M., Venkatakrishnan, A. J., Wilker, C. G., Badley, A. D., Razonable, R. R.
10.1101/2021.05.23.21257670 — Posted: 2021-05-25
How COVID-19 challenged care for women and their newborns: a qualitative case study of the experience of Belgian midwives during the first wave of the pandemic
Huysmans, E., Audet, C., Delvaux, T., Galle, A., Semaan, A., Asefa, A., Benova, L.
10.1101/2021.05.21.21257440 — Posted: 2021-05-25
Adverse events and their association with comorbidities after first and second doses of Covishield vaccination among healthcare workers of Government owned medical colleges in Kerala
A, R., Mathew, T., Nair, H., Rajasekharan Nair, G. L., Alex, M. R.
10.1101/2021.05.19.21257317 — Posted: 2021-05-25
COVID-19 County Level Severity Classification with Class Imbalance: A NearMiss Under-sampling Approach
Oladunni, T., Tossou, S., Haile, Y., Kidane, A.
10.1101/2021.05.21.21257603 — Posted: 2021-05-25
Monitoring of SARS-CoV-2 B.1.1.7 variant early-phase spreading in South-Moravian Region in the Czech Republic and evaluation of its pathogenicity
Vrbsky, J., Forte, G., Dvorackova, M., Diabelko, D., Ruzicka, F., Dvorakova Heroldova, M., Cundrle, I.
10.1101/2021.05.24.21257365 — Posted: 2021-05-25
A comparative study of SIR Model, Linear Regression, Logistic Function and ARIMA Model for forecasting COVID-19 cases
Abolmaali, S.
10.1101/2021.05.24.21257594 — Posted: 2021-05-25
Mask mandate and use efficacy in state-level COVID-19 containment
Guerra, D., Guerra, D. J.
10.1101/2021.05.18.21257385 — Posted: 2021-05-25 Discussion: Onsite
COVID-19 vaccination hesitancy model: The impact of vaccine education on controlling the outbreak in the United States
Oduro, B., Miloua, A., Apenteng, O. O., Osei, P. P.
10.1101/2021.05.21.21257612 — Posted: 2021-05-25
Psychological factors underpinning vaccine willingness in Israel, Japan and Hungary
Goodwin, R., Ben-Ezra, M., Takahashi, M., Nguyen Luu, L. A., Borsfay, K., Kovacs, M., Hou, W. K., Hamama-Raz, Y., Levin, Y.
10.1101/2021.05.24.21257465 — Posted: 2021-05-25

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).